Estramustine phosphate

Known as: Estramustin Phosphate, Estramustinphosphate, Phosphate, Estramustin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVES To determine the safety and efficacy of combination chemotherapy with docetaxel (DTX), estramustine phosphate (EMP… (More)
Is this relevant?
2005
2005
BACKGROUND Recent phase III studies in hormone refractory prostate cancer (HRPC) showed an improvement in terms of overall… (More)
Is this relevant?
2003
2003
BACKGROUND The combination of paclitaxel, oral estramustine phosphate (EMP), and carboplatin (TEC) has shown antitumor activity… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE To determine the safety and activity of weekly paclitaxel in combination with estramustine and carboplatin (TEC) in… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE To compare vinblastine versus the combination of vinblastine plus estramustine as treatment for patients with hormone… (More)
Is this relevant?
1999
1999
BACKGROUND To apply our preclinical findings of cytotoxic synergy with the combination of estramustine phosphate (EP) and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1988
1988
Plasma and tumour concentrations of estramustine, estromustine, estradiol and estrone, the major metabolites of estramustine… (More)
Is this relevant?
1988
1988
Estramustine phosphate (EMP) influence on human monocyte phagocytosis of fluorescein isothiocyanate (FITC)-labeled yeast cells… (More)
Is this relevant?
1985
1985
We have reported [(1984) Cancer Res., in press] that estramustine phosphate inhibits microtubule assembly and disassembled… (More)
Is this relevant?
1984
1984
The pharmacokinetics of estramustine phosphate (EMP) was studied in five prostatic cancer patients given single i.v. and oral… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?